VERV   $5.66  3.66% Market Closed After Close 5.6 -1.06%

Verve Therapeutics Inc
Total Cash 575.95M
totalCashPerShare 6.806
EBITDA -215.68M
Total Debt 72.48M
quickRatio 14.343
currentRatio 14.638
Total Revenue 20.65M
debtToEquity 13.272
Revenue/Share 0.275
ROA -0.21508
ROE -0.38099
grossProfits
freeCashflow -94.29M
operatingCashflow -129.73M
earningsGrowth
revenueGrowth 2.197
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins -8.79244
profitMargins 0.0
enterpriseValue -30.42M
forwardPE -1.898305
floatShares 62.40M
sharesOutstanding 84.62M
sharesShort 16.90M
sharesShortPriorMonth 16.33M
dateShortInterest
sharesPercentSharesOut 0.20%
heldPercentInsiders 0.02%
heldPercentInstitutions 0.92%
Short Ratio help_outline 12.09%
shortPercentOfFloat 0.24%
impliedSharesOutstanding
bookValue 6.459
Price To Book help_outline 0.87
earningsQuarterlyGrowth
netIncomeToCommon -192.65M
trailingEps -2.59%
forwardEps -2.95%
enterpriseToEbitda 0.14
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.7 3Q 2024
institutionsCount 242
lastUpdated Oct. 17, 2024, 12:03 a.m.